Miravo Healthcare™ to Present at Q1 Virtual Investor Summit

Rhea-AI Summary

On March 11, 2021, Nuvo Pharmaceuticals Inc. (OTCQX: MRVFF) announced that its President & CEO, Jesse Ledger, and Interim CFO, Kelly Demerino, will present at the Q1 Virtual Investor Summit on March 24, 2021, at 3:30 p.m. EST. The Investor Summit aims to connect smallcap and microcap companies with investors, featuring over 100 companies and 300 investors. Miravo, operating from Mississauga, Ontario, focuses on healthcare products targeting various therapeutic areas and adheres to strict GMP regulations.

- Wednesday, March 24^th - 3:30 p.m. EST -

MISSISSAUGA, ON, March 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals^® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo's President & Chief Executive Officer and Kelly Demerino, Miravo's Interim Chief Financial Officer will be presenting at the Q1 Virtual Investor Summit.

DATE:	Wednesday, March 24th, 2021
TIME:	3:30 p.m. EST
COMPLIMENTARY REGISTRATION:	https://zoom.us/webinar/register/WN_UHhzwEv6S3yGbrIbhK18Hw

About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. 
Please visit the website at www.investorsummitgroup.com

About Miravo Healthcare
Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company's manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-present-at-q1-virtual-investor-summit-301245111.html

SOURCE Nuvo Pharmaceuticals Inc.

FAQ

When is Miravo Healthcare presenting at the Q1 Virtual Investor Summit?

Miravo Healthcare will present at the Q1 Virtual Investor Summit on March 24, 2021, at 3:30 p.m. EST.

Who will represent Miravo Healthcare at the Investor Summit?

Jesse Ledger, President & CEO, and Kelly Demerino, Interim CFO, will represent Miravo Healthcare at the Investor Summit.

What is the focus of Miravo Healthcare's product portfolio?

Miravo Healthcare's products target therapeutic areas including pain, allergy, neurology, and dermatology.

What is the purpose of the Q1 Virtual Investor Summit?

The Q1 Virtual Investor Summit is designed to connect smallcap and microcap companies with qualified investors.

Where is Miravo Healthcare headquartered?

Miravo Healthcare is headquartered in Mississauga, Ontario, Canada.